Karl Mertens
- Epidemiology
- Infectious Diseases top 10%
- Critical Care and Intensive Care Medicine top 5%
- Applied Microbiology and Biotechnology top 1%
- Molecular Medicine top 5%
- Co-authors
- C. SuetensMarie‐Laurence LambertAnne SaveyMercedes PalomarAntonella AgodiM. HiesmayrUwe FrankMartin Schumacher
- Topics
- Emergency and Acute Care Studies (5 papers)Nosocomial Infections in ICU (5 papers)Antibiotic Use and Resistance (4 papers)
- Cited by
- Applied Microbiology and BiotechnologyCritical Care and Intensive Care MedicineMolecular Medicine
- Journals
- PLoS ONEBiometricsClinical Chemistry
In The Last Decade
Karl Mertens
16 papers receiving 522 citations
Peers
Comparison fields: 5 of 86
- Epidemiology 177
- Infectious Diseases 142
- Critical Care and Intensive Care Medicine 135
- Applied Microbiology and Biotechnology 135
- Molecular Medicine 117
Countries citing papers authored by Karl Mertens
This map shows the geographic impact of Karl Mertens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Mertens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Mertens more than expected).
Fields of papers citing papers by Karl Mertens
This network shows the impact of papers produced by Karl Mertens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Mertens. The network helps show where Karl Mertens may publish in the future.
Co-authorship network of co-authors of Karl Mertens
This figure shows the co-authorship network connecting the top 25 collaborators of Karl Mertens. A scholar is included among the top collaborators of Karl Mertens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Mertens. Karl Mertens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 14 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 22 | |
| 7 | 22 | |
| 8 | 14 | |
| 9 | 6 | |
| 10 | 292 | |
| 11 | 1 | |
| 12 | 18 | |
| 13 | 29 | |
| 14 | 20 | |
| 15 | 10 | |
| 16 | 45 | |
| 17 | 35 |
About Karl Mertens
Karl Mertens is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Clinical Biochemistry, having authored 17 papers that have together received 535 indexed citations. Recurring topics across this work include Emergency and Acute Care Studies (5 papers), Nosocomial Infections in ICU (5 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (135 citations), Critical Care and Intensive Care Medicine (135 citations) and Molecular Medicine (117 citations). Karl Mertens has collaborated with scholars based in Belgium, Sweden and Austria. Frequent co-authors include C. Suetens, Marie‐Laurence Lambert, Anne Savey, Mercedes Palomar, Antonella Agodi, M. Hiesmayr, Uwe Frank, Martin Schumacher, Ingrid Moráles and Martin Wolkewitz. Their work appears in journals such as PLoS ONE, Biometrics and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.